Johanna Kessel
Goethe University Frankfurt
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Johanna Kessel.
Cancer | 2018
Sebastian Scheich; Sarah Lindner; Rosalie Koenig; Claudia Reinheimer; Thomas A. Wichelhaus; Michael Hogardt; Silke Besier; Volkhard A. J. Kempf; Johanna Kessel; Hans Martin; Anne C. Wilke; Hubert Serve; Gesine Bug; Björn Steffen
Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a curative treatment option for patients with acute myeloid leukemia (AML). During transplantation, patients undergo a period of severe neutropenia, which puts them at high risk for infectious complications. However, the impact of patient colonization with multidrug‐resistant organisms (MDRO) on overall survival remains unclear.
Biology of Blood and Marrow Transplantation | 2017
Sebastian Scheich; Claudia Reinheimer; Christian T. Brandt; Thomas A. Wichelhaus; Michael Hogardt; Volkhard A. J. Kempf; Uta Brunnberg; Christian Brandts; Olivier Karl Friedrich Ballo; Ivana von Metzler; Johanna Kessel; Hubert Serve; Björn Steffen
A significant increase in infections caused by multidrug-resistant organisms (MDRO) has been observed in recent years, resulting in an increase of mortality in all fields of health care. Hematological patients are particularly affected by MDRO infections because of disease- and therapy-related immunosuppression. To determine the impact of colonization with MDRO on overall survival, we retrospectively analyzed data from patients undergoing autologous hematopoietic stem cell transplantation at our institution. In total, 184 patients were identified, mainly patients with lymphomas (n = 98, 53.3%), multiple myelomas (n = 80, 43.5%), germ cell cancers (n = 5, 2.7%), or acute myeloid leukemia (n = 1, .5%). Forty patients (21.7%) tested positive for MDRO colonization. At a median follow-up time of 21.5 months, the main causes of death were infection in colonized and disease progression in noncolonized patients. Nonrelapse mortality (NRM) was higher in patients who tested positive for MDRO than in the noncolonized group (25.4% versus 3%, P < .001). Interestingly, NRM in neutropenia after autologous transplantation did not differ between colonized and noncolonized patients. Colonized patients, however, had inferior overall survival after autologous transplantation in univariate (61.7% versus 73.3%, P = .005) as well as in multivariate analysis (hazard ratio, 2.463; 95% confidence interval, 1.311 to 4.626; P = .005). We conclude that the period after discharge from hospital after autologous transplantation seems critical and patients with MDRO colonization should be observed closely for infections in the post-transplantation period in outpatient care.
Antimicrobial Resistance and Infection Control | 2017
Lena M. Biehl; Hartmut Bertz; Johannes R. Bogner; Ute-Helke Dobermann; Johanna Kessel; Carolin Krämer; Sebastian Lemmen; Marie von Lilienfeld-Toal; Silke Peter; Mathias Wilhelm Rudolf Pletz; Holger Rohde; Stefan Schmiedel; Sören Schubert; Andrew J. Ullmann; Gerd Fätkenheuer; Maria J.G.T. Vehreschild
To assess the scope of infection control measures for multidrug-resistant bacteria in high-risk settings, a survey among university hospitals was conducted. Fourteen professionals from 8 sites participated. Reported policies varied largely with respect to the types of wards conducting screening, sample types used for screening and implementation of contact precautions. This variability among sites highlights the need for an evidence-based consensus of current infection control policies.
Journal of Clinical Microbiology | 2017
Jan Springer; P. Lewis White; Johanna Kessel; Imke Wieters; Daniel Teschner; Daniel Korczynski; Tobias Liebregts; Oliver A. Cornely; Stefan Schwartz; Thomas Elgeti; Lisa Meintker; Stefan W. Krause; Raquel B. Posso; Werner J. Heinz; Sandra Fuhrmann; Jörg J. Vehreschild; Hermann Einsele; Volker Rickerts; Juergen Loeffler
ABSTRACT In patients with hematological malignancies, bronchoalveolar lavage fluid (BALF) specimens are commonly used for the diagnosis of mold infections. However, it is not clear whether the cell pellet (P) or the supernatant fraction (S) of the BALF specimen is optimal for molecular diagnostic testing. Thus, 99 BALF specimens were collected from 96 hematology patients with or without allogeneic hematopoietic stem cell transplant. The cell pellets and supernatants were processed alone and in combination (S/P) for testing by two fungus-specific real-time PCR assays compliant with international recommendations. The results achieved with S/P were revealed to be superior in comparison to those achieved with S and P alone, with the use of each single fraction showing a reduced sensitivity for the detection of Aspergillus DNA (82% and 43% for S and P, respectively). In 57% of the samples, testing of the combination of S and P generated a lower quantification cycle value than testing of S or P alone. Molds would have been missed in 5 and 16 out of 28 samples if only S or P, respectively, was analyzed. No sample was positive by testing of S or P only. Similar results were obtained for the detection of Mucorales DNA in BALF specimens (reduced sensitivity of 67% and 50% for S and P, respectively). Study patients were categorized according to the current European Organization for the Research and Treatment of Cancer/Mycoses Study Group classification for invasive fungal disease (IFD), revealing that 35 patients had proven/probable IFD (36%), 47 patients had possible IFD (49%), and 14 patients had undetermined IFD (15%).
BMC Infectious Diseases | 2017
Marcus M. Mücke; Johanna Kessel; Victoria T. Mücke; Katharina Schwarzkopf; Michael Hogardt; Christoph Stephan; Stefan Zeuzem; Volkhard A. J. Kempf; Christian Lange
BackgroundPyogenic liver abscesses (PLA) remain a significant clinical problem. Unfortunately, little is known about current bacterial susceptibility profiles and the incidence of multidrug resistant organisms (MDROs) causing PLA in Western countries. Yet, this crucial information is pivotal to guide empirical antibiotic therapy. Aim of this study was to provide detailed characteristics of PLA with a special focus on underlying bacterial pathogens and their susceptibility to antibiotics.MethodsA retrospective study of patients diagnosed with PLA from 2009 to 2015 in a large tertiary reference center in Germany was performed in order to characterize PLA and antimicrobial susceptibility profiles of causative bacterial species.ResultsOverall, 86 patients were included. The most common causes of PLA were bile duct stenosis/obstruction (31.4%) and leakage of biliary anastomosis (15.1%). Frequent predisposing diseases were malignancies (34.9%), diabetes (24.4%) and the presence of liver cirrhosis (16.3%). Of note, Enterococcus spp. were the most frequently cultured bacterial isolates (28.9%), and in 1/3 of cases vancomycin resistance was observed. In addition, a relevant frequency of gram-negative MDROs was identified. In particular, an alarming 10% and 20% of gram-negative bacteria were resistant to carbapenems and tigecycline, respectively. Of note, MDRO status did not predict ICU stay or survival in multivariate regression analysis. The mortality rate in our series was 16.3%.ConclusionOur study demonstrates an as yet underreported role of Enterococcus spp., often associated with vancomycin resistance, as well as of gram-negative MDROs causing PLA.
World Journal of Gastroenterology | 2016
Mireen Friedrich-Rust; Beate Wanger; Florian Heupel; Natalie Filmann; Reinhard Brodt; Volkhard A. J. Kempf; Johanna Kessel; Thomas A. Wichelhaus; Eva Herrmann; Stefan Zeuzem; Jörg Bojunga
AIM To assess the rate of infection, appropriateness of antimicrobial-therapy and mortality on intensive care unit (ICU). Special focus was drawn on patients with liver cirrhosis. METHODS The study was approved by the local ethical committee. All patients admitted to the Internal Medicine-ICU between April 1, 2007 and December 31, 2009 were included. Data were extracted retrospectively from all patients using patient charts and electronic documentations on infection, microbiological laboratory reports, diagnosis and therapy. Due to the large hepatology department and liver transplantation center, special interest was on the subgroup of patients with liver cirrhosis. The primary statistical-endpoint was the evaluation of the influence of appropriate versus inappropriate antimicrobial-therapy on in-hospital-mortality. RESULTS Charts of 1979 patients were available. The overall infection-rate was 53%. Multiresistant-bacteria were present in 23% of patients with infection and were associated with increased mortality (P < 0.000001). Patients with infection had significantly increased in-hospital-mortality (34% vs 17%, P < 0.000001). Only 9% of patients with infection received inappropriate initial antimicrobial-therapy, no influence on mortality was observed. Independent risk-factors for in-hospital-mortality were the presence of septic-shock, prior chemotherapy for malignoma and infection with Pseudomonas spp. Infection and mortality-rate among 175 patients with liver-cirrhosis was significantly higher than in patients without liver-cirrhosis. Infection increased mortality 2.24-fold in patients with cirrhosis. Patients with liver cirrhosis were at an increased risk to receive inappropriate initial antimicrobial therapy. CONCLUSION The results of the present study report the successful implementation of early-goal-directed therapy. Liver cirrhosis patients are at increased risk of infection, mortality and to receive inappropriate therapy. Increasing burden are multiresistant-bacteria.
PLOS ONE | 2018
Sebastian Scheich; Rosalie Koenig; Anne C. Wilke; Sarah Lindner; Claudia Reinheimer; Thomas A. Wichelhaus; Michael Hogardt; Volkhard A. J. Kempf; Johanna Kessel; Sarah Weber; Hans Martin; Gesine Bug; Hubert Serve; Björn Steffen
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) offers potential cure to acute myeloid leukemia (AML) patients. However, infections with commensal bacteria are an important cause for non-relapse mortality (NRM). We have previously described the impact of multidrug-resistant organism (MDRO) colonization on the survival of allo-HSCT patients. In the aforementioned publication, according to consensus, we there did not consider the opportunistic gram-negative bacterium Stenotrophomonas maltophilia (S. maltophilia) to be an MDRO. Since rate of S. maltophilia colonization is increasing, and it is not known whether this poses a risk for allo-HSCT patients, we here analyzed here its effect on the previously described and now extended patient cohort. We report on 291 AML patients undergoing allo-HSCT. Twenty of 291 patients (6.9%) were colonized with S. maltophilia. Colonized patients did not differ from non-colonized patients with respect to their age, remission status before allo-HSCT, donor type and HSCT-comorbidity index. S. maltophilia colonized patients had a worse overall survival (OS) from 6 months up to 60 months (85% vs. 88.1% and 24.7% vs. 59.7%; p = 0.007) due to a higher NRM after allo-HSCT (6 months: 15% vs. 4.8% and 60 months: 40.1% vs. 16.2% p = 0.003). The main cause of mortality in colonized patients was infection (46.2% of all deaths) and in non-colonized patients relapse (58.8% of all deaths). 5/20 colonized patients developed an invasive infection with S. maltophilia. The worse OS after allo-HSCT due to higher infection related mortality might implicate the screening of allo-HSCT patients for S. maltophilia and a closer observation of colonized patients as outpatients.
European Journal of Haematology | 2018
Sebastian Scheich; Sarah Weber; Rosalie König; Anne C. Wilke; Sarah Lindner; Claudia Reinheimer; Thomas A. Wichelhaus; Michael Hogardt; Volkhard A. J. Kempf; Johanna Kessel; Hans Martin; Gesine Bug; Hubert Serve; Björn Steffen
In hematology and oncology, in particular in the setting of allogeneic hematopoietic stem cell transplantation (allo‐HSCT), vancomycin‐resistant Enterococcus spp. (VRE) colonization rates are high due to previous hospital stays and preceding antibiotic treatment and colonized patients have a lower overall survival (OS).
Deutsche Medizinische Wochenschrift | 2017
Johanna Kessel; Barbara Dolff; Thomas A. Wichelhaus; Nils Keiner; Michael Hogardt; Claudia Reinheimer; Imke Wieters; Sebastian Harder; Volkhard A. J. Kempf; Christoph Stephan; für das Antibiotic-Stewardship-Team
Annals of Hematology | 2018
Sebastian Scheich; Sarah Weber; Claudia Reinheimer; Thomas A. Wichelhaus; Michael Hogardt; Volkhard A. J. Kempf; Johanna Kessel; Hubert Serve; Björn Steffen